Substituted piperidines as renin inhibitors

Details for Australian Patent Application No. 2009211378 (hide)

Owner Novartis AG

Inventors Herold, Peter; Mah, Robert; Jelakovic, Stjepan; Tschinke, Vincenzo; Behnke, Dirk

Agent Davies Collison Cave

Pub. Number AU-A-2009211378

PCT Pub. Number WO2009/098276

Priority 08101428.4 08.02.08 EP

Filing date 6 February 2009

Wipo publication date 13 August 2009

International Classifications

C07D 413/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

A61K 31/445 (2006.01) - Non-condensed piperidines, e.g. piperocaine

A61P 9/12 (2006.01) Drugs for disorders of the cardiovascular system

C07D 413/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

Event Publications

5 August 2010 PCT application entered the National Phase

  PCT publication WO2009/098276 Priority application(s): WO2009/098276

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009211379-Flaviviridae mutants comprising a deletion in the capsid protein for use as vaccines

2009211377-Substituted piperidines as renin inhibitors